Oncoinvent ASA: Share capital decrease completed

Oslo, Norway, 5 May 2026: Reference is made to the stock exchange announcement made by Oncoinvent ASA (the "Company") on 8 January 2026 regarding the resolution by the extraordinary general meeting to decrease the share capital of the Company by NOK 222,800,997, from NOK 223,920,600 to NOK 1,119,603, through a reduction of the nominal value of the shares by NOK 49.75, from NOK 50 to NOK 0.25.

The resolution was published by the Norwegian Register of Business Enterprises on 22 January 2026 and followed by a six-week creditor notice period, which was completed without creditor objections.

The share capital decrease has today been registered as completed by the Norwegian Register of Business Enterprises. Following the share capital decrease, the share capital of the Company is NOK 1,119,603, divided into 4,478,412 shares, each with a nominal value of NOK 0.25.